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19 Four-arm robotic lobectomy for the treatment of early-stage lung cancer
Giulia Veronesi, MD, Domenico Galetta, MD, Patrick Maisonneuve, DipEng, Franca Melfi, MD,
Ralph Alexander Schmid, MD, Alessandro Borri, MD, Fernando Vannucci, MD, and Lorenzo
Spaggiari, MD, PhD, Milan and Pisa, Italy; and Berne, Switzerland
We present our experience with four-arm robotic surgery for lung lobectomy with mediastinal node
dissection. It is practicable, safe, and associated with shorter postoperative hospitalization than
open surgery. The number of lymph nodes sampled suggests that the procedure is oncologically
adequate.PM
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S26 Risk factor analysis for postoperative acute respiratory distress syndrome and
early mortality after pneumonectomy: The predictive value of preoperative
lung perfusion distribution
Joon Bum Kim, MD, Sei Won Lee, MD, Seung-Il Park, MD, Yong Hee Kim, MD, and Dong Kwan
Kim, MD, Seoul and Seongnam, Korea
After pneumonectomy, multivariable analyses identified lower predicted postoperative forced
expiratory volume in 1 second and higher perfusion fraction of resected lung as predictors of
postoperative acute respiratory distress syndrome and early mortality.(continued on page 12A)
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S32 Aprospective, randomized trial comparing BioGlue andVivostat for the control
of alveolar air leak
Elizabeth Belcher, MRCP, FRCS, PhD, Michael Dusmet, MD, Simon Jordan, FRCS, MD,
George Ladas, FRCS, FETCS, Eric Lim, FRCS, MSc, and Peter Goldstraw, FRCS, London,
United Kingdom
Although BioGlue has been shown to be efficacious in the control of airleak after thoracic surgery,
Vivostat has inherent advantages as a sealant. In a randomized, controlled trial of BioGlue versus
Vivostat in the control of alveolar airleak, there were no differences in duration of airleak, intercostal
drainage, or hospital stay.
39 Double-bar application decreases postoperative pain after the Nuss procedure
Tomohisa Nagaso, MD, Junpei Miyamoto, MD, Kiyokazu Kokaji, MD, Ryohei Yozu, MD,
Hua Jiang, MD, HongMei Jin, and Tamotsu Tamaki, PhD, Tokyo and Nippon, Japan; and
Shanghai, China
We investigated whether double-bar application reduces pain after the Nuss procedure. Patients who
received double-bar application had less pain than those with single-bar application, which was
further supported by a biomechanical study demonstrating that stresses on the thoraces are reduced by
additional bar application.
45 A randomized, controlled study of amiodarone for prevention of atrial
fibrillation after transthoracic esophagectomy
James E. Tisdale, PharmD, Heather A. Wroblewski, MSN, Donna S. Wall, PharmD,Karen M. Rieger, MD, Zane T. Hammoud, MD, Jerry V. Young, MD, and Kenneth A. Kesler, MD,
Indianapolis, Ind
Patients undergoing esophagectomy randomly received amiodarone (n = 40) or no prophylaxis
(control, n = 40). The incidence of atrial fibrillation was lower in the amiodarone group than in the
control group (15% vs 40%, P = .02, relative risk reduction 62.5%). Amiodarone significantly
reduced the incidence of atrial fibrillation after esophagectomy.Acquired Cardiovascular
Disease (ACD)52 Endovascular repair of aortic arch lesions in high-risk patients or after previous
aortic surgery: Midterm results
Ludovic Canaud, MD, Kheira Hireche, MD, Jean-Philippe Berthet, MD, Pascal Branchereau, MD,
Charles Marty-Ane´, MD, PhD, and Pierre Alric, MD, PhD, Montpellier, France
The aim of this study is to assess the midterm outcomes after endovascular repair of aortic arch lesions
in high-risk patients or after previous aortic surgery. Hybrid endovascular aortic arch reconstructions
provide an attractive alternative for treating aortic arch lesions in high-risk patients.
59 Determinants of in-hospital and long-term surgical outcomes after repair of
postinfarction ventricular septal rupture
Satsuki Fukushima, MD, PhD, Peter J. Tesar, FRACS, Homayoun Jalali, FRACS, Andrew J. Clarke,
FRACS, Hemant Sharma,MCh, Jivesh Choudhary, MCh, Harry Bartlett, PhD, and Peter G. Pohlner,
FRACS, Chermside and Brisbane, Australia
A consecutive series of 68 patients who underwent repair of postinfarction VSR was studied with
a mean follow-up period of 9.26 4.9 years. Thirty-day mortality was 35%, and actuarial survival of
30-day survivors was 51% at 15 years. Predictors of long-term congestive cardiac failure and
ventricular arrhythmia varied.(continued on page 13A)
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Griffin, FRCS(C-Th), Michael E. Cowen, FRCS, Alexander R. Cale, MD, FRCS (C-Th), and Levent
Guvendik, FRCS, East Yorkshire, United Kingdom
Small coronary diameter and extensive atherosclerosis, increasingly encountered in current practice,
pose operative difficulties. This study reports the impact of grafting poor-quality coronary targets and
incomplete revascularization, which can result from avoiding such vessels, on early postoperative
major adverse cardiac events.
73 Long-term (5- to 20-year) patency of the radial artery for coronary bypass
grafting
Paul Achouh, MD, Redha Boutekadjirt, MD, Daniel Toledano, MD, Nadjib Hammoudi, MD,
Jean-Yves Pagny, MD, Pascal Goube, MD, Khaled Ould Isselmou, MD, Bernard Lancelin, MD,
Re´gis Fouquet, MD, and Christophe Acar, MD, Paris and Corbeil, France
Angiographic evaluation of the radial artery graft was performed after 5 to 20 years in 202 patients.
Patency of radial arteries was 83% at 10.5 years, which was similar to previously reported patency
rates at 1 year and 5 years.CH
D80 Influence of timing of intraaortic balloon placement in cardiac surgical patients
Jayshree D. Lavana, MBBS, MD, FJFICM, John F. Fraser, MB ChB, MRCP, FRCA, FFARCSI,
FJFICM, Susan E. Smith, BSc (Hons), Lesley Drake, BBusHA (HIM), Peter Tesar, MBBS, FRCS, and
Daniel V. Mullany, MBBS, FANZCA, FJICM, Brisbane, Queensland, Australia
This study evaluated the association of timing of intraaortic balloon placement with outcomes in
cardiac surgical patients. Observed in-hospital and risk-adjusted mortality were lower in patients
receiving preoperative compared with intraoperative or postoperative balloon pumps.TX86 Quality of mitral valve repair: Median sternotomy versus port-access approach
Ehud Raanani, MD, Dan Spiegelstein, MD, Leonid Sternik, MD, Sergey Preisman, MD, Yaron
Moshkovitz, MD, Aram K. Smolinsky, MD, and Amihai Shinfeld, MD, Tel Aviv, Israel
The durability of minimally invasive mitral valve repair has not been well investigated. One hundred
forty-three patients underwent surgical intervention for posterior leaflet pathology: 61 through the
port-access and 82 through the sternotomy approach. Late echocardiographic analysis revealed that
82% (49/60) of patients with port access and 91% (73/80) of patients with sternotomy were free from
moderate or severe mitral regurgitation (P = .11).
PM
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S91 Mortality after coronary artery revascularization of patients with rheumatoid
arthritis
Joji J. Varghese, MD, Sushma Koneru, MD, Steven L. Scaife, MS, Whitney E. Zahnd, MS, and
Mark L. Francis, MD, Springfield, Ill
Among all patients undergoing either percutaneous coronary interventions or coronary artery bypass
grafting, patients with rheumatoid arthritis were 49% less likely to die while hospitalized after
adjusting for confounding variables. Patients with rheumatoid arthritis undergoing either procedure
also had reduced lengths of hospitalization and reduced total hospital charges.(continued on page 14A)
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S97 A new approach to interventional atrioventricular valve therapy
Andreas Goetzenich, MD, Guido Dohmen, MD, Nima Hatam, MD, Thorsten Deichmann, Dipl-Ing,
Christoph Schmitz, Dipl-Ing, Andreas H. Mahnken, MD, PhD, Ru¨diger Autschbach, MD, PhD, and
Jan Spillner, MD, Aachen, Germany
We show the functionality of an additional heart valve prosthesis placed in a complex, collapsible,
and self-expanding hollow body, adapting to surrounding structures and excluding the left atrium.We
show that anchoring an additional heart valve in the mitral position does not necessarily need to be
performed in the heart valve structure itself.
103 Nonelective cardiac surgery in the elderly: Is it justified?
Ravi K. Ghanta, MD, Prem S. Shekar, MD, Siobhan McGurk, BS, Donna M. Rosborough, RN, MS,
and Sary F. Aranki, MD, Boston, Mass
We review the long-term survival and quality-of-life outcomes of 262 consecutive octogenarians and
nonagenarians who underwent nonelective cardiac surgery. Survival and postoperative quality of life
after nonelective cardiac surgery equals that of the general elderly population. Age alone should not
disqualify a patient for urgent or emergent cardiac surgery.
110 How much of the intraaortic balloon volume is displaced toward the coronary
circulation?
Christina Kolyva, PhD, George M. Pantalos, PhD, John R. Pepper, MChir, FRCS, and Ashraf W.
Khir, PhD, Middlesex and London, United Kingdom; and Louisville, Ky
The blood volume displaced toward the coronary circulation during intraaortic balloon inflation was
assessed in vivo and in vitro. This volume was approximately 5% of the nominal volume of the
intraaortic balloon. Although small, this volume can provide significant augmentation in baseline
coronary flow.
117 How much septal–lateral mitral annular reduction do you get with new
ischemic/functional mitral regurgitation annuloplasty rings?
Wolfgang Bothe, MD, Julia C. Swanson, MD, Neil B. Ingels, PhD, andD. CraigMiller, MD, Stanford
and Palo Alto, Calif
The amount of disproportionate mitral annular septal–lateral reduction inherent in new ischemic/
functional mitral regurgitation annuloplasty rings is unknown. Relative to the Edwards Physio ring,
the GeoForm provides the greatest degree of septal–lateral reduction, followed by the IMR ETlogix
and Medtronic Profile 3D, whereas the St Jude Medical Rigid Saddle Annuloplasty Ring’s septal–
lateral dimensions were similar.
122 Changes in cardiac and cognitive function and self-reported outcomes at one
year after coronary artery bypass grafting
Lars Mathisen, MS, Per Snorre Lingaas, MD, Marit Helen Andersen, PhD, Per Kristian Hol, MD,
PhD, Per Morten Fredriksen, PhD, Kjetil Sundet, PhD, Berit Rokne, PhD, Astrid Klopstad Wahl,
PhD, and Erik Fosse, MD, PhD, Oslo and Bergen, Norway
Individual changes in cardiac performance, cognitive function, and angina, assessed at 1
postoperative year, were significant for subjective health status relative to the predictions possible
from preoperative health status, sex, and graft patency. Awareness of the extent and impact of
outcome variation on health status is important when counseling patients.(continued on page 16A)
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Disease (CHD)16A The Journal of Thoracic an129 Fenestration during Fontan palliation: Now the exception instead of the rule
Jorge D. Salazar, MD, Farhan Zafar, MD, Kashif Siddiqui, MD, Ryan D. Coleman, BA, David L. S.
Morales, MD, Jeffrey S. Heinle, MD, JosephW. Rossano, MD, Emad B.Mossad, MD, and Charles D.
Fraser, Jr, MD, Houston, Tex
Highly selective use of fenestration during Fontan palliation preserves excellent short- and long-
term outcomes while avoiding the risks of hypoxia, paradoxic embolus, and need for late catheter-
based interventions. Increased use of extracardiac conduits is associated with decreased use of
fenestration.
137 Chronologic changes in P-wave characteristics after the Fontan procedure:
The effect of surgical modification
Masahiro Koh, MD, Hideki Uemura, MD, Akiko Kada, MPH, Koji Kagisaki, MD, Ikuo Hagino, MD,
and Toshikatsu Yagihara, MD, Osaka, Japan, and London, United Kingdom
P-wave characteristics were analyzed chronologically after 3 types of Fontan-type procedures.
Changes in P-wave characteristics over time showed that intra-atrial baffling and atriopulmonary
connection caused a similar trend toward a propensity to development of arrhythmia. An extracardiac
conduit was associated with unchanged P-wave characteristics, supporting this procedure as the
preferred option.
144 Genetic factors are important determinants of impaired growth after infant
cardiac surgery
Nancy Burnham, RN, MSN, CRNP, Richard F. Ittenbach, PhD, Virginia A. Stallings, MD, Marsha
Gerdes, PhD, Elaine Zackai, MD, Judy Bernbaum, MD, Robert R. Clancy, MD, and J. William
Gaynor, MD, Philadelphia, Pa, and Cincinnati, Ohio
Impaired growth for both weight and head circumference is common (both .30%) in this cohort of
children after infant cardiac surgery. Genetic factors such as the apolipoprotein E 32 allele and the
presence of a definite or suspected genetic syndrome were associated with impaired growth velocity.
Persistent poor growth might have long-term implications for the health and development of children
with congenital heart defects.
150 Patent ductus arteriosus ligation is associated with impaired left ventricular
systolic performance in premature infants weighing less than 1000 g
Patrick J. McNamara, MB Bch MRCPCH, Lilian Stewart, MD, Sandesh P. Shivananda, MD,Derek Stephens, MSc, and Arvind Sehgal, MD, Toronto, Ontario, Canada
Patent ductus arteriosus ligation is associated with cardiorespiratory instability. The nature of the
deterioration may relate to impaired left ventricular performance, particularly in neonates weighing
,1000 g.
158 Early and delayed atrioventricular conduction block after routine surgery
for congenital heart disease
Angela Lin, BS, William T. Mahle, MD, Patricio A. Frias, MD, Peter S. Fischbach, MD, Brian E.
Kogon, MD, Kirk R. Kanter, MD, and Paul M. Kirshbom, MD, Cleveland, Ohio, and Atlanta, Ga
Surgery for congenital cardiac disease involving VSD closure can result in early or delayed AV block.
A review of 922 patients a median of 4.1 years after surgery demonstrated a 2.3% incidence of
postoperative AV block (1.4% transient, 0.9% permanent) and a 0.3% to 0.7% incidence of delayed
AV block 2 to 34 months after surgery.(continued on page 18A)
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Transplantation (TX)18A The Journal of Thoracic an161 AUnited Network for Organ Sharing analysis of heart transplantation in adults
with congenital heart disease: Outcomes and factors associated with mortality
and retransplantation
Tara Karamlou, MD, MSc, Jennifer Hirsch, MD, MS, Karl Welke, MD, MS, Richard G. Ohye, MD,
Edward L. Bove, MD, Eric J. Devaney, MD, and Robert J. Gajarski, MD, Ann Arbor, Mich, and
Portland, Ore
Outcomes and risk factors for mortality and retransplantation (RTx) among patients with adult
congenital heart disease (ACHD) were compared with those of other adult recipients (ARs).
Transplantation prevalence increased by 41% among patients with ACHD, with a decrease in
prevalence for ARs. Both death and RTx rates were higher among patients with ACHD, possibly
because of differences in posttransplantation immunosuppression therapy.
169 The impact of bridge-to-transplant ventricular assist device support on survival
after cardiac transplantation
David A. Bull, MD, Bruce B. Reid, MD, Craig H. Selzman, MD, RebeccaMesley, BS, Stavros Drakos,
MD, Steven Clayson, MD, Greg Stoddard, PhD, Edward Gilbert, MD, Josef Stehlik, MD, Feras
Bader, MD, Abdallah Kfoury, MD, Deborah Budge, MD, David D. Eckels, PhD, Anne Fuller, BS,
Dale Renlund, MD, and Amit N. Patel, MD, Salt Lake City and Murray, Utah
In patients with idiopathic dilated cardiomyopathy, placement of a Heartmate I (Thoratec Corp,
Pleasanton, Calif) ventricular assist device as a bridge to a cardiac transplant is associated with an
elevation in pretransplant panel-reactive antibody sensitization and a decrease in 1- and 5-year
survivals after cardiac transplantation.
174 Post–cardiac transplant survival after support with a continuous-flow left
ventricular assist device: Impact of duration of left ventricular assist device
support and other variables
Ranjit John, MD, Francis D. Pagani, MD, Yoshifumi Naka, MD, Andrew Boyle, MD, John V. Conte,
MD, Stuart D. Russell, MD, Charles T. Klodell, MD, Carmelo A. Milano, MD, Joseph Rogers, MD,
David J. Farrar, PhD, and O. Howard Frazier, MD, Minneapolis, Minn, Ann Arbor, Mich, New
York, NY, Baltimore, Md, Gainesville, Fla, Durham, NC, Pleasanton, Calif, and Houston, Tex
Post–cardiac transplant survival in patients supported with continuous-flow devices such as the
HeartMate II LVAD is equivalent to that with conventional transplantation. Further, posttransplant
survival is not influenced by the duration of LVAD support. The improved durability and reduced
short- and long-term morbidity associated with the HeartMate II LVAD has reduced the need for
urgent cardiac transplantation, which may have adversely influenced survival in the pulsatile
LVAD era.Perioperative
Management (PM)182 Effect of b-blocker use on outcomes after discharge in patients who underwent
cardiac surgery
Anita Y. M. Chan, PhD, Finlay A. McAlister, MD, MSc, Colleen M. Norris, PhD, David Johnstone,
MD, FACC, Jeffrey A. Bakal, PhD, and David B. Ross, MD, for the Alberta Provincial Program for
Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators, Edmonton, Alberta,
Canada
In a prospective cohort of 3102 patients followed after cardiac surgery, discharge use of b-blockers
was associated with lower 1- and 6-year mortality, even after adjusting for covariates. b-Blocker users
exhibited lower mortality rates in all subgroups after nontransplant cardiac surgery, including those
without heart failure or myocardial infarction.(continued on page 20A)
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S188 Leukoreduction program for red blood cell transfusions in coronary surgery:
Association with reduced acute kidney injury and in-hospital mortality
Gianpaolo Romano, MD, Ciro Mastroianni, MD, Ciro Bancone, MD, Alessandro Della Corte, MD,
PhD, FEACTS, Nicola Galdieri, MD, Gianantonio Nappi, FEACTS, and Luca Salvatore De Santo,
FEACTS, Naples and Foggia, Italy
Definitive evidence for or against implementation of universal leukocyte reduction in cardiac surgery
is still lacking. In this before-and-after cohort study of 1034 consecutive patients undergoing
coronary artery bypass grafting, adoption of a prestorage leukoreduction program was associated
with reduced acute kidney injury and hospital mortality in a propensity-matched analysis.Evolving Technology/
Basic Science (ET/BS)196 Technical considerations to avoid pitfalls during transapical aortic valve
implantation
Daniel R. Wong, MD, MPH, Jian Ye, MD, Anson Cheung, MD, John G. Webb, MD, Ronald G.
Carere, MD, and Samuel V. Lichtenstein, MD, PhD, Vancouver, British Columbia, Canada
TAVI has been performed with good results. Complications can often be mitigated by adhering to
lessons learned from the early experience with this technology.203 Efficacy of a novel bipolar radiofrequency ablation device on the beating heart
for atrial fibrillation ablation: A long-term porcine study
Rochus K. Voeller, MD, Andreas Zierer, MD, Shelly C. Lall, MD, Shun-ichiro Sakamoto, MD,
Richard B. Schuessler, PhD, and Ralph J. Damiano, Jr, MD, St Louis, Mo
In this porcine study, the bipolar radiofrequency ablation device Isolator II (AtriCure, Inc, Cincinnati,
Ohio) was able to create reliable long-term transmural lesions of the modified Cox maze procedure on
the beating heart without cardiopulmonary bypass 100% of the time.209 Sustained local application of epidermal growth factor to accelerate
reepithelialization of tracheal grafts
Jinbo Zhao, MD, Yong Han, MD, Zhibo Liang, MD, Zhipei Zhang, PhD, Qiang Lu, MD, Xiaolong
Yan, MD, and Xiaofei Li, MD, Shaanxi, China
Gelatin microspheres were prepared as sustained-release vectors for epidermal growth factor and
locally applied to tracheal allografts. In a murine orthotopic tracheal transplant model, sustained local
application of epidermal growth factor accelerated epithelial regeneration after orthotopic tracheal
transplant without increasing fibrosis.216 In vitro functional comparison of therapeutically relevant human vasculogenic
progenitor cells used for cardiac cell therapy
Yan Zhang, MD, MSc, Serena Wong, BSc, Jessica Lafle`che, BSc, Suzanne Crowe, Thierry G.
Mesana, MD, PhD, Erik J. Suuronen, PhD, and Marc Ruel, MD, MPH, Ottawa, Ontario, Canada
This study compared the vasculogenic functions of clinically relevant progenitor cells and
demonstrated that a novel source of expandable CD1331 cells from the CD1332 fraction of
peripheral blood was vasculogenically more potent than other progenitors. Intercellular interactions
were functionally important and can be used to improve the efficacy of cell therapies.(continued on page 21A)
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CD225 Loss of p53, rather than beta-catenin overexpression, induces survivin-
mediated resistance to apoptosis in an esophageal cancer cell line
Elizabeth Chang, BS, James Donahue, MD, Anna Smith, BS, John Hornick, BS, MS, Jaladanki N.
Rao, PhD, Jian-Ying Wang, MD, PhD, and Richard J. Battafarano, MD, PhD, Baltimore, Md
Survivin is overexpressed in TE7 esophageal cancer cells and plays a critical role in resistance to
camptothecin-induced apoptosis. Changes in transcriptional regulation of survivin contribute to its
overexpression in TE7 cells. Loss of p53, rather than overexpression of beta-catenin, seems to be
a more important factor in survivin overexpression.
233 Dor procedure for dyskinetic anteroapical myocardial infarction fails to
improve contractility in the border zone
Kay Sun, PhD, Zhihong Zhang, MS, Takamaro Suzuki, MD, Jonathan F. Wenk, PhD, Nielen Stander,
PhD, Daniel R. Einstein, PhD, David A. Saloner, PhD, Arthur W. Wallace, MD, PhD, Julius M.
Guccione, PhD, andMark B. Ratcliffe, MD, San Francisco and Livermore, Calif; and Olympia, Wash
Animal specific finite element models of sheep before and after the Dor procedure were created. The
Dor procedure decreases end-diastolic and end-systolic stress but fails to improve contractility in the
infarct border zone.Brief Technique ReportsCH
D
TX240 Balloon sizing in surgical ventricular restoration: What volume are we
targeting?
Ellen A. ten Brinke, MD, Robert J. Klautz, MD, PhD, and Paul Steendijk, PhD, Leiden, The
Netherlands
242 Is pneumonectomy mandatory after transection of the left main pulmonary
artery?
Ugonna N. Ihekweazu, BS, William D. Travis, MD, and Raja M. Flores, MD, New York, NY
244 Mediastinoscopy-assisted minimally invasive closure of a bronchopleural
fistula: A new technique to manage an old problem
Shawn S. Groth, MD, Jonathan D’Cunha, MD, PhD, Natasha M. Rueth, MD, Rafael S. Andrade,
MD, and Michael A. Maddaus, MD, Minneapolis, Minn
246 Transcatheter valve-in-valve implantation for the treatment of stentless aortic
valve dysfunction
Josep Rode´s-Cabau, MD, FESC, Eric Dumont, MD, Daniel Doyle, MD, and Jeroˆme Lemieux, MD,
Quebec City, Quebec, CanadaPM
248 Balloon-guided, tapered, Polyflex stent guidance: An atraumatic technique for
successful stent placement through tight, rigid airway stenoses
Moishe Liberman, MD, and John C. Wain, MD, Montreal, Quebec, Canada, and Boston, MassOnline Only: Brief
Clinical ReportsET
/B
Se1 Intraoperative assessment after pediatric cardiac surgical repair: Initial
experience with C-arm angiography
Jeffrey H. Shuhaiber, MD, Lisa Bergersen, MD, Frank Pigula, MD, Sitaram Emani, MD, Doff
McElhinney, MD, Audrey Marshall, MD, Francis Fynn-Thompson, MD, and Emile A. Bacha, MD,
Boston, Mass
e3 Mitral and tricuspid valve repair 21 years after cardiac transplantation
Joss Fernandez, MD, Djurabek Babadjanov, MD, and Robert Saeid Farivar, MD, PhD, Iowa City,
Iowa(continued on page 22A)
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Se5 Agenesis of the left carotid artery in the right aortic arch with Kommerell
diverticulum
Atsushi Nakahira, MD, PhD, Hidekazu Hirai, MD, PhD, Yasuyuki Sasaki, MD, PhD, and Shigefumi
Suehiro, MD, PhD, Osaka, Japan
e7 Early thrombus in a HeartMate II left ventricular assist device: A potential
cause of hemolysis and diagnostic dilemma
Castigliano M. Bhamidipati, DO, Gorav Ailawadi, MD, James Bergin, MD, and John A. Kern, MD,
Charlottesville, Va
e9 Caseous calcification of the anterior mitral valve annulus presenting as
intracardiac mass
Sotiris C. Stamou, MD, Alan C. Braverman, MD, and Nicholas T. Kouchoukos, MD, St Louis, Mo
e11 Mitral valve lipomatous hamartoma infiltrating myocardium
Aarne Jyrala, MD, and Gregory L. Kay, MD, Los Angeles, Calif
e12 Fontan completion in patient with pulmonary artery sling associated with
hypoplastic left heart syndrome
Yasuhiro Kotani, MD, PhD, Kozo Ishino, MD, PhD, Osami Honjo, MD, PhD, and Shunji Sano, MD,
PhD, Okayama City, Japan
e14 Incidental discovery of an ascending aortic thrombus: Should this patient
undergo surgical intervention?
Subhasis Chatterjee, MD, Susan S. Eagle, MD, David H. Adler, MD, and John G. Byrne, MD,
Nashville, Tenn
e16 Mechanical left ventricular unloading to prevent recurrent myocardial rupture
Stephen Westaby, MS, PhD, Vipin Mehta, MD, Fidelma Flynn, MD, and Neil Wilson, MD, Oxford,
United Kingdom
e18 Ascending aortic injury caused by a fractured sternal wire 28 years after
surgical intervention of pectus excavatum
Shigetoshi Mieno, MD, Hideki Ozawa, MD, and Takahiro Katsumata, MD, Takatsuki, Osaka, Japan
e20 Mediastinoscopy-assisted ligation of an aberrant right subclavian artery
through a supraclavicular approach
Narain Moorjani, MD, FRCS, Nancy Mohsen, MD, and Percy Boateng, MD, Philadelphia, PaLetters to the Editor 250 Standardization of transplant procurement procedures
Phil Botha, MRCS, Stephen C. Clark, FRCS(Cth), and John H. Dark, FRCS, Newcastle upon Tyne,
United Kingdom
250 Reply to the Editor
Michael K. Pasque, MD, St Louis, Mo
251 How can we prevent functional mitral stenosis after surgery?
Yasushige Shingu, MD, PhD, and Yoshiro Matsui, MD, PhD, Sapporo, Japan
252 Reply to the Editor
Yutaka Otsuji, MD, Ryuzo Sakata, MD, Kayoko Kubota, MD, Robert A. Levine, MD, and Chuwa Tei,
MD, Kitakyushu, Kyoto, and Kagoshima, Japan; and Boston, Mass
253 Effect of cyclophosphamide on myocardial ischemia/reperfusion injury in rats
Bikash Medhi, MBBS, MD (AIIMS), MAMS, FIMSA, Sharonjeet Kaur, and Ajay Prakash, MSc,
Chandigarh, India
254 Reply to the Editor
Yuan-gang Qiu, MD, Hangzhou, Zhejiang, China(continued on page 24A)
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Filipe Moreira de Andrade, MD, Omar Mote´ AbouMourad, MD, and Luiz Felippe Judice, MD, PhD,
Nitero´i-RJ, Brazil
254 Reply to the Editor
Orhan Saim Demirtu¨rk, MD, Hasan Hakan Atalay, MD, Dalokay Kılıc¸, MD, and Rıza Tu¨rko¨z, MD,
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